semaglutide efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial The Importance of Patient-Reported Outcomes

GLP-1 medications, initially developed to manage blood sugar levels in individuals with type 2 diabetes, have gained popularity for their effectiveness in promoting weight loss

Keep in mind that all medications come with their risks and benefits

Limited observational data and small case series suggest additive weight loss when both agents are used together, but no large randomized controlled trials directly compare monotherapy versus combination treatment

Some patients experience sleep disruptions during the initial weeks of treatment

First and foremost, we have to start with nutrition

Some doctors are prescribing Ozempic off-label for weight loss, but it doesnt have U.S